Click Therapeutics snags $52m Series B

Click Therapeutics Inc, a provider of digital therapeutics as prescription medical treatments, has raised $52 million in Series B financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this